share_log

Assure | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Assure | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Assure | NT 10-Q：季报延迟披露公告
美股sec公告 ·  05/16 17:28
Moomoo AI 已提取核心信息
Assure Holdings Corp., a company listed in the United States, has notified the SEC of a delay in filing its quarterly report on Form 10-Q for the period ended March 31, 2024. The delay is due to technical accounting issues related to the disposition of assets to National Neuromonitoring Services, LLC, which was completed on March 26, 2024. Assure requires additional time to finalize its financial statements for inclusion in the Form 10-Q. The company anticipates filing the report by May 20, 2024, which is within the five-day extension period allowed under Rule 12b-25. Assure has confirmed that all other periodic reports have been filed as required. The company also expects to report a significant change in its financial results, with anticipated revenue of approximately $10,000 for...Show More
Assure Holdings Corp., a company listed in the United States, has notified the SEC of a delay in filing its quarterly report on Form 10-Q for the period ended March 31, 2024. The delay is due to technical accounting issues related to the disposition of assets to National Neuromonitoring Services, LLC, which was completed on March 26, 2024. Assure requires additional time to finalize its financial statements for inclusion in the Form 10-Q. The company anticipates filing the report by May 20, 2024, which is within the five-day extension period allowed under Rule 12b-25. Assure has confirmed that all other periodic reports have been filed as required. The company also expects to report a significant change in its financial results, with anticipated revenue of approximately $10,000 for the quarter, down from $3.6 million in the same period the previous year. The expected net loss for the quarter is approximately $3.1 million, an improvement from the $4.3 million net loss reported for the quarter ended March 31, 2023. These changes are primarily due to the reclassification of revenue from clinical operations to discontinued operations and the sale of these clinical operations.
在美国上市的公司Assure Holdings Corp. 已通知美国证券交易委员会，延迟提交截至2024年3月31日的10-Q表季度报告。延迟是由于与向国家神经监测服务有限责任公司处置资产有关的技术会计问题，该处置于2024年3月26日完成。Assure需要更多时间来完成其财务报表以纳入10-Q表中。该公司预计将在2024年5月20日之前提交报告，该报告是在第12b-25条允许的五天延期内。Assure 已确认所有其他定期报告均已按要求提交。该公司还预计其财务业绩将发生重大变化，本季度预计收入约为1万美元，低于去年同期的360万美元。本季度的预期净亏损约为310万美元，较截至2023年3月31日的季度报告的430万美元净亏损有所改善。这些变化主要是由于将收入从临床业务重新归类为已终止业务以及出售这些临床业务。
在美国上市的公司Assure Holdings Corp. 已通知美国证券交易委员会，延迟提交截至2024年3月31日的10-Q表季度报告。延迟是由于与向国家神经监测服务有限责任公司处置资产有关的技术会计问题，该处置于2024年3月26日完成。Assure需要更多时间来完成其财务报表以纳入10-Q表中。该公司预计将在2024年5月20日之前提交报告，该报告是在第12b-25条允许的五天延期内。Assure 已确认所有其他定期报告均已按要求提交。该公司还预计其财务业绩将发生重大变化，本季度预计收入约为1万美元，低于去年同期的360万美元。本季度的预期净亏损约为310万美元，较截至2023年3月31日的季度报告的430万美元净亏损有所改善。这些变化主要是由于将收入从临床业务重新归类为已终止业务以及出售这些临床业务。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息